Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sheldon W Tobe

Showing results (101-110 of 154) with videos related to

Pageof 16
Sort By:
The Canadian Journal of Cardiology|November 26, 2013
Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education ProgramNadia A Khan, Robert J Herman, Robert R Quinn, et al.
Implementation Science : IS|May 4, 2015
I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventionsMarion Maar, Karen Yeates, Marcia Barron, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 27, 2018
Diagnosing hypertension in Indigenous Canadians (DREAM-GLOBAL): A randomized controlled trial to compare the effectiveness of short message service messaging for management of hypertension: Main resultsSheldon W Tobe, Karen Yeates, Norm R C Campbell, et al.
CJC Open|December 11, 2020
Patient- and Physician-Level Factors Associated With Adherence to C-CHANGE Recommendations in Primary Care Settings in OntarioTheresa Min-Hyung Lee, Sheldon W Tobe, Debra A Butt, et al.
Diabetes Care|January 22, 2024
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE TrialsSheldon W Tobe, Thomas A Mavrakanas, Harpreet S Bajaj, et al.
Journal of Alzheimer'S Disease : JAD|July 22, 2017
Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort StudyJodi D Edwards, Joel Ramirez, Brandy L Callahan, et al.
BMC Endocrine Disorders|May 12, 2009
DreamTel; Diabetes risk evaluation and management tele-monitoring study protocolSheldon W Tobe, Joan Wentworth, Laurie Ironstand, et al.
JMIR Mhealth and Uhealth|January 24, 2016
Unpacking the Black Box: A Formative Research Approach to the Development of Theory-Driven, Evidence-Based, and Culturally Safe Text Messages in Mobile Health InterventionsMarion A Maar, Karen Yeates, Zsolt Toth, et al.
Diabetes, Obesity & Metabolism|March 21, 2023
Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCEMichael A Tsoukas, Vincent Woo, Sheldon W Tobe, et al.
The Canadian Journal of Cardiology|May 12, 2020
Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Resistant HypertensionSwapnil Hiremath, Ruth Sapir-Pichhadze, Meranda Nakhla, et al.
Pageof 16

Showing results (101-110 of 154) with videos related to

Sort By:
Pageof 16
The Canadian Journal of Cardiology|November 26, 2013
Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education ProgramNadia A Khan, Robert J Herman, Robert R Quinn, et al.
Implementation Science : IS|May 4, 2015
I-RREACH: an engagement and assessment tool for improving implementation readiness of researchers, organizations and communities in complex interventionsMarion Maar, Karen Yeates, Marcia Barron, et al.
Journal of Clinical Hypertension (Greenwich, Conn.)|November 27, 2018
Diagnosing hypertension in Indigenous Canadians (DREAM-GLOBAL): A randomized controlled trial to compare the effectiveness of short message service messaging for management of hypertension: Main resultsSheldon W Tobe, Karen Yeates, Norm R C Campbell, et al.
CJC Open|December 11, 2020
Patient- and Physician-Level Factors Associated With Adherence to C-CHANGE Recommendations in Primary Care Settings in OntarioTheresa Min-Hyung Lee, Sheldon W Tobe, Debra A Butt, et al.
Diabetes Care|January 22, 2024
Impact of Canagliflozin on Kidney and Cardiovascular Outcomes by Type 2 Diabetes Duration: A Pooled Analysis of the CANVAS Program and CREDENCE TrialsSheldon W Tobe, Thomas A Mavrakanas, Harpreet S Bajaj, et al.
Journal of Alzheimer'S Disease : JAD|July 22, 2017
Antihypertensive Treatment is associated with MRI-Derived Markers of Neurodegeneration and Impaired Cognition: A Propensity-Weighted Cohort StudyJodi D Edwards, Joel Ramirez, Brandy L Callahan, et al.
BMC Endocrine Disorders|May 12, 2009
DreamTel; Diabetes risk evaluation and management tele-monitoring study protocolSheldon W Tobe, Joan Wentworth, Laurie Ironstand, et al.
JMIR Mhealth and Uhealth|January 24, 2016
Unpacking the Black Box: A Formative Research Approach to the Development of Theory-Driven, Evidence-Based, and Culturally Safe Text Messages in Mobile Health InterventionsMarion A Maar, Karen Yeates, Zsolt Toth, et al.
Diabetes, Obesity & Metabolism|March 21, 2023
Cardiovascular and kidney outcomes with canagliflozin according to type 2 diabetes treatment targets at baseline: Data from the CANVAS programme and CREDENCEMichael A Tsoukas, Vincent Woo, Sheldon W Tobe, et al.
The Canadian Journal of Cardiology|May 12, 2020
Hypertension Canada's 2020 Evidence Review and Guidelines for the Management of Resistant HypertensionSwapnil Hiremath, Ruth Sapir-Pichhadze, Meranda Nakhla, et al.
Pageof 16